ALX Oncology Holdings Inc. (ALXO) vs Coherus Oncology, Inc. (CHRS)
A side-by-side comparison of ALX Oncology Holdings Inc. and Coherus Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALXO
ALX Oncology Holdings Inc.
$1.19HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
CHRS
Coherus Oncology, Inc.
$1.07HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — ALXO vs CHRS
growth of $100 · dividends reinvested · last 6yALXO -96.0% (-41.4%/yr)CHRS -93.9% (-37.2%/yr)CHRS compounded faster over this window
ALXO CHRS
ALXO vs CHRS: by the numbers
- •CHRS is the larger company ($165M vs $159M market cap).
- •Both run net losses; ALXO's is the smaller (0.00% vs -257.10% net margin).
Metrics side by side
Valuation
| Metric | ALXO | CHRS |
|---|---|---|
| P/S ratio | N/A | 3.23 |
| P/B ratio | 1.17 | 2.70 |
Profitability
| Metric | ALXO | CHRS |
|---|---|---|
| Gross margin | 0.00% | 63.55% |
| Operating margin | 0.00% | -425.72% |
| Net margin | 0.00% | -257.10% |
| ROE | -59.40% | -215.26% |
| ROIC | -56.53% | -135.38% |
Growth (annualized)
| Metric | ALXO | CHRS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -33.60% |
| Total return CAGR (5Y) | -56.07% | -41.38% |
Frequently asked
- How have ALXO and CHRS total returns compared?
- Over the past 5 years, ALXO delivered -56.07% and CHRS delivered -41.38% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.